INCY ▼ -2.8% - Incyte Corporation
$INCY Povofortay® (povorcitinib) Approved in Europe as the First Once-Daily Oral Treatment for Adults with Moderate to Severe Hidradenitis Suppurativa
16-NOV-2026 04:31 PM ET
Share this post
More filings for $INCY
INCY - Incyte Corporation - SEC Filing Update (12-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 12, 2026INCY ▲ +0.2% - Incyte CorporationOct 29, 2026INCY ▼ -1.7% - Incyte CorporationOct 26, 2026
View full $INCY filing history →💬 Comments
Loading comments…
Leave a comment
